The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity

Frontiers in Immunology

Volumn 4, Issue JUN, 2013, Pages

  Gallo, Paul M ^a   Gallucci, Stefania ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acidosis; Autoimmunity; DAMPs; Dendritic cells; Hypoxia; Mitochondria; Nanomaterial; Osmolarity

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INFLAMMASOME; NANOMATERIAL; NUCLEIC ACID; PURINERGIC P2X7 RECEPTOR; STROMAL CELL DERIVED FACTOR 1; URIC ACID;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; DENDRITIC CELL; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; HYPOXIA; IMMUNE RESPONSE; INFLAMMATION; MITOCHONDRION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84883785469     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00138     Document Type: Review

References (261)

1. Abdulahad, D. A., Westra, J., Bijzet, J., Limburg, P. C., Kallenberg, C. G., and Bijl, M. (2011). High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Arthritis Res. Ther. 13, R71. doi:10.1186/ar3332
2. Adachi, Y., Taketani, S., Toki, J., Ikebukuro, K., Sugiura, K., Oyaizu, H., et al. (2002). Marked increase in number of dendritic cells in autoimmune-prone (NZW x BXSB)F1 mice with age. Stem Cells 20, 61-72. doi:10.1634/stemcells.20-1-61
3. Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., and Mcneil, S. E. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61, 428-437. doi:10.1016/j.addr.2009.03.009
4. Amodio, G., and Gregori, S. (2012). Dendritic cells a double-edge sword in autoimmune responses. Front. Immunol. 3:233. doi:10.3389/fimmu.2012.00233
5. Andersson, A., Covacu, R., Sunnemark, D., Danilov, A., Dal Bianco, A., Khademi, M., et al. (2008). Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J. Leukoc. Biol. 84, 1248-1255. doi:10.1189/jlb.1207844
6. Andón, F. T., and Fadeel, B. (2013). Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc. Chem. Res. 46, 733-742.
7. Arcangeli, A., and Becchetti, A. (2006). Complex functional interaction between integrin receptors and ion channels. Trends Cell Biol. 16, 631-639. doi:10.1016/j.tcb.2006.10.003
8. Arnoult, D., Soares, F., Tattoli, I., and Girardin, S. E. (2011). Mitochondria in innate immunity. EMBO Rep. 12, 901-910. doi:10.1038/embor.2011.157
9. Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., et al. (2008). ATP drives lamina propria T(H)17 cell differentiation. Nature 455, 808-812. doi:10.1038/nature07240
10. Aymeric, L., Apetoh, L., Ghiringhelli, F., Tesniere, A., Martins, I., Kroemer, G., et al. (2012). Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 70, 855-858. doi:10.1158/0008-5472.CAN-09-3566
11. Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., et al. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U.S.A. 100, 2610-2615. doi:10.1073/pnas.0337679100
12. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., et al. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811. doi:10.1146/annurev.immunol.18.1.767
13. Barrat, F. J., Meeker, T., Chan, J. H., Guiducci, C., and Coffman, R. L. (2007). Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur. J. Immunol. 37, 3582-3586. doi:10.1002/eji.200737815
14. Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., et al. (2005). Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202, 1131-1139. doi:10.1084/jem.20050914
15. Basu, S., Binder, R. J., Suto, R., Anderson, K. M., and Srivastava, P. K. (2000). Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12, 1539-1546. doi:10.1093/intimm/12.11.1539
16. Behrens, E. M., Sriram, U., Shivers, D. K., Gallucci, M., Ma, Z., Finkel, T. H., et al. (2007). Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J. Immunol. 178, 6268-6279.
17. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., et al. (2003). Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723. doi:10.1084/jem.20021553
18. Bianchi, M. E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1-5. doi:10.1189/jlb.0306164
19. Bianchi, M. E., Beltrame, M., and Paonessa, G. (1989). Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243, 1056-1059. doi:10.1126/science.2922595
20. Binder, R. J., Han, D. K., and Srivastava, P. K. (2000). CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1, 151-155. doi:10.1038/77835
21. Biswas, C., Sriram, U., Ciric, B., Ostrovsky, O., Gallucci, S., and Argon, Y. (2006). The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells. Int. Immunol. 18, 1147-1157. doi:10.1093/intimm/dxl049
22. Blander, J. M., and Medzhitov, R. (2004). Regulation of phagosome maturation by signals from toll-like receptors. Science 304, 1014-1018. doi:10.1126/science.1096158
23. Blengio, F., Raggi, F., Pierobon, D., Cappello, P., Eva, A., Giovarelli, M., et al. (2013). The hypoxic environment reprograms the cytokine/chemokine expression profile of human mature dendritic cells. Immunobiology 218, 76-89. doi:10.1016/j.imbio.2012.02.002
24. Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., et al. (2003). Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22, 5551-5560. doi:10.1093/emboj/cdg516
25. Bondanza, A., Zimmermann, V. S., Dell'Antonio, G., Dal Cin, E., Capobianco, A., Sabbadini, M. G., et al. (2003). Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J. Immunol. 170, 24-27.
26. Bosco, M. C., Pierobon, D., Blengio, F., Raggi, F., Vanni, C., Gattorno, M., et al. (2011). Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117, 2625-2639. doi:10.1182/blood-2010-06-292136
27. Brennan, T. V., Lin, L., Huang, X., Cardona, D. M., Li, Z., Dredge, K., et al. (2012). Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood 120, 2899-2908. doi:10.1182/blood-2011-07-368720
28. Cahalan, M. D., Wulff, H., and Chandy, K. G. (2001). Molecular properties and physiological roles of ion channels in the immune system. J. Clin. Immunol. 21, 235-252. doi:10.1023/A:1010958907271
29. Caicedo, M. S., Desai, R., Mcallister, K., Reddy, A., Jacobs, J. J., and Hallab, N. J. (2009). Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity. J. Orthop. Res. 27, 847-854. doi:10.1002/jor.20826
30. Cardone, R. A., Casavola, V., and Reshkin, S. J. (2005). The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat. Rev. Cancer 5, 786-795. doi:10.1038/nrc1713
31. Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., et al. (2008). The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U.S.A. 105, 9035-9040. doi:10.1073/pnas.0803933105
32. Castiglioni, A., Canti, V., Rovere-Querini, P., and Manfredi, A. A. (2011). High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res. 343, 189-199. doi:10.1007/s00441-010-1033-1
33. Cella, M., Engering, A., Pinet, V., Pieters, J., and Lanzavecchia, A. (1997). Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787. doi:10.1038/42030
34. Chen, M., Wang, Y. H., Wang, Y., Huang, L., Sandoval, H., Liu, Y. J., et al. (2006). Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311, 1160-1164. doi:10.1126/science.1122545
35. Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., et al. (2012). Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat. Immunol. 13, 832-842. doi:10.1038/ni.2376
36. Cho, Y. S., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., et al. (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123. doi:10.1016/j.cell.2009.05.037
37. Christensen, B. N., Kochukov, M., Mcnearney, T. A., Taglialatela, G., and Westlund, K. N. (2005). Proton-sensing G protein-coupled receptor mobilizes calcium in human synovial cells. Am. J. Physiol. Cell Physiol. 289, C601-C608. doi:10.1152/ajpcell.00039.2005
38. Collins, L., Hajizadeh, S., Holme, E., Jonsson, I.-M., and Tarkowski, A. (2004). Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J. leukoc. Biol. 75, 995-1000. doi:10.1189/jlb.0703328
39. Colonna, L., Dinnall, J. A., Shivers, D. K., Frisoni, L., Caricchio, R., and Gallucci, S. (2006). Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus. Arthritis Res. Ther. 8, R49. doi:10.1186/ar1911
40. Compan, V., Baroja-Mazo, A., López-Castejón, G., Gomez, A. I., Martínez, C. M., Angosto, D., et al. (2012). Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37, 487-500. doi:10.1016/j.immuni.2012.06.013
41. Cramer, T., Yamanishi, Y., Clausen, B. R. E., Förster, I., Pawlinski, R., Mackman, N., et al. (2003). HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657. doi:10.1016/S0092-8674(03)00154-5
42. Crow, M. K., Kirou, K. A., and Wohlgemuth, J. (2003). Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36, 481-490. doi:10.1080/08916930310001625952
43. Dandona, P., Ghanim, H., Green, K., Sia, C., Abuaysheh, S., Kuhadiya, N., et al. (2013). Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients. Am. J. Physiol. Endocrinol. Metab. 304, 8. doi:10.1152/ajpendo.00566.2012
44. de Baey, A., and Lanzavecchia, A. (2000). The role of aquaporins in dendritic cell macropinocytosis. J. Exp. Med. 191, 743-748. doi:10.1084/jem.191.4.743
45. Debler, J., Schiemann, U., Seybold, U., Mussack, T., Landauer, N., Ladurner, R., et al. (2003). Heat-shock protein HSP70-2 genotypes in patients with Crohn's disease: a more severe clinical course with intestinal complications in presence of the PstI-polymorphism. Eur. J. Med. Res. 8, 120-124.
46. Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., et al. (2009). Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27, 3013-3021. doi:10.1016/j.vaccine.2009.03.034
47. Desai, B. N., Myers, B. R., and Schreiber, S. L. (2002). FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc. Natl. Acad. Sci. U.S.A. 99, 4319-4324. doi:10.1073/pnas.261702698
48. Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., and Mcneil, S. E. (2008). Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 5, 487-495. doi:10.1021/mp800032f
49. Dobrovolskaia, M. A., and McNeil, S. E. (2007). Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2, 469-478. doi:10.1038/nnano.2007.223
50. Dröge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95. doi:10.1152/physrev.00018.2001
51. Dumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Herrmann, M., Nawroth, P. P., et al. (2005). Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J. Immunol. 174, 7506-7515. doi:10.1038/nature06939
52. Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S., and Flavell, R. A. (2008). Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122-1126. doi:10.1038/nature06939
53. Elamanchili, P., Lutsiak, C. M. E., Hamdy, S., Diwan, M., and Samuel, J. (2007). "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. J. Immunother. 30, 378-395. doi:10.1097/CJI.0b013e31802cf3e3
54. Elkon, K. B., and Stone, V. V. (2011). Type I interferon and systemic lupus erythematosus. J. Interferon Cytokine Res. 31, 803-812. doi:10.1089/jir.2011.0045
55. Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., et al. (2009). Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461, 282-286. doi:10.1038/nature08296
56. Eloranta, M. L., Lovgren, T., Finke, D., Mathsson, L., Ronnelid, J., Kastner, B., et al. (2009). Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum. 60, 2418-2427. doi:10.1002/art.24686
57. Eriksson, U., Ricci, R., Hunziker, L., Kurrer, M. O., Oudit, G. Y., Watts, T. H., et al. (2003). Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9, 1484-1490. doi:10.1038/nm960
58. Escames, G., López, L. C., García, J. A., García-Corzo, L., Ortiz, F., and Acuña-Castroviejo, D. (2011). Mitochondrial DNA and inflammatory diseases. Hum. Genet. 131, 161-173. doi:10.1007/s00439-011-1057-y
59. Fadeel, B. (2012). Clear and present danger? Engineered nanoparticles and the immune system. Swiss Med. Wkly. 142:w13609. doi:10.4414/smw.2012.13609
60. Fadeel, B., Pietroiusti, A., and Shvedova, A. (2012). Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health. Boston: Academic Press.
61. Fahmy, T. M., Fong, P. M., Park, J., Constable, T., and Saltzman, W. M. (2007). Nanosystems for simultaneous imaging and drug delivery to T cells. AAPS J. 9, E171-180. doi:10.1208/aapsj0902019
62. Feili-Hariri, M., Falkner, D. H., and Morel, P. A. (2002). Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur. J. Immunol. 32, 2021-2030. doi:10.1002/1521-4141(200207)32:7<2021::AID-IMMU2021>3.0.CO;2-J
63. Flohe', S. B., Bruggemann, J., Lendemans, S., Nikulina, M., Meierhoff, G., Flohe', S., et al. (2003). Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 170, 2340-2348.
64. Frisoni, L., Mcphie, L., Colonna, L., Sriram, U., Monestier, M., Gallucci, S., et al. (2005). Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for autoimmunity?. J. Immunol. 175, 2692-2701.
65. Furnrohr, B. G., Wach, S., Kelly, J. A., Haslbeck, M., Weber, C. K., Stach, C. M., et al. (2010). Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus. Ann. Rheum. Dis. 69, 1983-1989. doi:10.1136/ard.2009.122630
66. Gall, A., Treuting, P., Elkon, K. B., Loo, Y. M., Gale, M. Jr., Barber, G. N., et al. (2012). Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36, 120-131. doi:10.1016/j.immuni.2011.11.018
67. Gallucci, S., Lolkema, M., and Matzinger, P. (1999). Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249-1255. doi:10.1038/15200
68. Gallucci, S., and Matzinger, P. (2001). Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13, 114-119. doi:10.1016/S0952-7915(00)00191-6
69. Galluzzi, L., Kepp, O., and Kroemer, G. (2012). Mitochondria: master regulators of danger signalling. Nat. Rev. Mol. Cell Biol. 13, 780-788. doi:10.1038/nrm3479
70. Garber, S. S., and Cahalan, M. D. (1997). Volume-regulated anion channels and the control of a simple cell behavior. Cell. Physiol. Biochem. 7, 229-241. doi:10.1159/000154877
71. Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., et al. (2011). Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20. doi:10.1126/scitranslmed.3001201
72. García-Vallejo, J., Ambrosini, M., Overbeek, A., Van Riel, W., Bloem, K., Unger, W., et al. (2013). Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol. Immunol. 53, 387-397. doi:10.1016/j.molimm.2012.09.012
73. Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., et al. (2002). The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 995-1001. doi:10.1093/embo-reports/kvf198
74. Gergely, P. Jr., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., et al. (2002). Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 46, 175-190. doi:10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H
75. Germain, R. N. (2012). Maintaining system homeostasis: the third law of Newtonian immunology. Nat. Immunol. 13, 902-906. doi:10.1038/ni.2404
76. Gerner, M. Y., Kastenmuller, W., Ifrim, I., Kabat, J., and Germain, R. N. (2012). Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. Immunity 37, 364-376. doi:10.1016/j.immuni.2012.07.011
77. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., et al. (2009). Activation of the NLRP3 inflammasome in dendritic cells induces IL-1Œ ≤,äí dependent adaptive immunity against tumors. Nat. Med. 15, 1170-1178. doi:10.1038/nm.2028
78. Ginhoux, F., Ng, L. G., and Merad, M. (2012). Understanding the murine cutaneous dendritic cell network to improve intradermal vaccination strategies. Curr. Top. Microbiol. Immunol. 351, 1-24. doi:10.1007/82_2010_115
79. Gloire, G., Legrand-Poels, S., and Piette, J. (2006). NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72, 1493-1505. doi:10.1016/j.bcp.2006.04.011
80. Goh, F. G., and Midwood, K. S. (2011). Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 51, 7-23. doi:10.1093/rheumatology/ker257
81. Goldstein, R. S., Gallowitsch-Puerta, M., Yang, L., Rosas-Ballina, M., Huston, J. M., Czura, C. J., et al. (2006). Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25, 571-574. doi:10.1097/01.shk.0000209540.99176.72
82. Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., et al. (2006). Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107, 2013-2021. doi:10.1182/blood-2005-05-1795
83. Gris, D., Ye, Z., Iocca, H. A., Wen, H., Craven, R. R., Gris, P., et al. (2010). NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185, 974-981. doi:10.4049/jimmunol.0904145
84. Grivennikov, S. I. (2013). Inflammation and colorectal cancer: colitis-associated neoplasia. Semin. Immunopathol. 35, 229-244. doi:10.1007/s00281-012-0352-6
85. Gunther, C., Meurer, M., Stein, A., Viehweg, A., and Lee-Kirsch, M. A. (2009). Familial chilblain lupus - a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1. Dermatology (Basel) 219, 162-166. doi:10.1159/000222430
86. Hammer, G. E., and Ma, A. (2013). Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu. Rev. Immunol. 31, 743-791. doi:10.1146/annurev-immunol-020711-074929
87. Han, J., Zhong, J., Wei, W., Wang, Y., Huang, Y., Yang, P., et al. (2008). Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 57, 2118-2127. doi:10.2337/db07-1499
88. Harley, I. T., Kaufman, K. M., Langefeld, C. D., Harley, J. B., and Kelly, J. A. (2009). Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat. Rev. Genet. 10, 285-290. doi:10.1038/nrg2571
89. Harris, H. E., Andersson, U., and Pisetsky, D. S. (2012). HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8, 195-202. doi:10.1038/nrrheum.2011.222
90. Hartmann, H., Eltzschig, H. K., Wurz, H., Hantke, K., Rakin, A., Yazdi, A. S., et al. (2008). Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology 134, 756-767. doi:10.1053/j.gastro.2007.12.008
91. Heil, M., Ibarra-Laclette, E., Adame-Alvarez, R. M., Martinez, O., Ramirez-Chavez, E., Molina-Torres, J., et al. (2012). How plants sense wounds: damaged-self recognition is based on plant-derived elicitors and induces octadecanoid signaling. PLoS ONE 7:e30537. doi:10.1371/journal.pone.0030537
92. Hilbi, H. (2009). Bacterial jailbreak sounds cellular alarm: phagosome membrane remnants trigger signaling. Cell Host Microbe 6, 102-104. doi:10.1016/j.chom.2009.08.001
93. Hollander, A. P., Corke, K. P., Freemont, A. J., and Lewis, C. E. (2001). Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44, 1540-1544. doi:10.1002/1529-0131(200107)44:7¡1540::AID-ART277.3.0.CO;2-7
94. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., et al. (2008). Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847-856. doi:10.1038/ni.1631
95. Hur, J. W., Sung, Y. K., Shin, H. D., Park, B. L., Cheong, H. S., and Bae, S. C. (2008). TREX1 polymorphisms associated with autoantibodies in patients with systemic lupus erythematosus. Rheumatol. Int. 28, 783-789. doi:10.1007/s00296-007-0509-0
96. Hwang, I. I. L., Watson, I. R., Der, S. D., and Ohh, M. (2006). Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response. J. Virol. 80, 10712-10723. doi:10.1128/JVI.01014-06
97. Ichimonji, I., Tomura, H., Mogi, C., Sato, K., Aoki, H., Hisada, T., et al. (2010). Extracellular acidification stimulates IL-6 production and Ca(2+) mobilization through proton-sensing OGR1 receptors in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 299, L567-L577. doi:10.1152/ajplung.00415.2009
98. Iyer, S. S., Pulskens, W. P., Sadler, J. J., Butter, L. M., Teske, G. J., Ulland, T. K., et al. (2009). Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 106, 20388-20393. doi:10.1073/pnas.0908698106
99. Jancic, C. C., Cabrini, M., Gabelloni, M. L., Rodríguez Rodrigues, C., Salamone, G., Trevani, A. S., et al. (2011). Low extracellular pH stimulates the production of IL-1Œ ≤ by human monocytes. Cytokine 57, 258-268. doi:10.1016/j.cyto.2011.11.013
100. Janeway, C. A. Jr. (1992). The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11-16. doi:10.1016/0167-5699(92)90198-G
101. Janeway, C. J. (1989). Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1-13. doi:10.1101/SQB.1989.054.01.003
102. Jantsch, J., Chakravortty, D., Turza, N., Prechtel, A. T., Buchholz, B. R., Gerlach, R. G., et al. (2008). Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J. Immunol. 180, 4697-4705.
103. Javaherian, K., Liu, J. F., and Wang, J. C. (1978). Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. Science 199, 1345-1346. doi:10.1126/science.628842
104. Jeong, H.-J., Chung, H.-S., Lee, B.-R., Kim, S.-J., Yoo, S.-J., Hong, S.-H., et al. (2003). Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem. Biophys. Res. Commun. 306, 805-811. doi:10.1016/S0006-291X(03)01073-8
105. Jiang, W., and Pisetsky, D. S. (2008). Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann. Rheum. Dis. 67, 727-728. doi:10.1136/ard.2007.074484
106. Jouan-Lanhouet, S., Arshad, M. I., Piquet-Pellorce, C., Martin-Chouly, C., Le Moigne-Muller, G., Van Herreweghe, F., et al. (2012). TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ. 19, 2003-2014. doi:10.1038/cdd.2012.90
107. Julian, M., Shao, G., Bao, S., Knoell, D., Papenfuss, T., Vangundy, Z., et al. (2012). Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J. immunol. 189, 433-443. doi:10.4049/jimmunol.1101375
108. Kaba, N. K., and Knauf, P. A. (2001). Hypotonicity induces L-selectin shedding in human neutrophils. Am. J. Physiol. Cell Physiol. 281, C1403-C1407.
109. Kalled, S. L., Cutler, A. H., and Burkly, L. C. (2001). Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment. J. Immunol. 167, 1740-1747.
110. Katzourakis, A., and Gifford, R. J. (2010). Endogenous viral elements in animal genomes. PLoS Genet. 6:e1001191. doi:10.1371/journal.pgen.1001191
111. Kim, J., and Mooney, D. J. (2011). In vivo modulation of dendritic cells by engineered materials: towards new cancer vaccines. Nano Today 6, 466-477. doi:10.1016/j.nantod.2011.08.005
112. Kleinewietfeld, M., Manzel, A., Titze, J., Kvakan, H., Yosef, N., Linker, R., et al. (2013). Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518-522. doi:10.1038/nature11868
113. Knippertz, I., Stein, M. F., Dorrie, J., Schaft, N., Muller, I., Deinzer, A., et al. (2011). Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int. J. Hyperthermia 27, 591-603. doi:10.3109/02656736.2011.589234
114. Koike, E., Takano, H., Inoue, K.-I., Yanagisawa, R., and Kobayashi, T. (2008). Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells. Chemosphere 73, 371-376. doi:10.1016/j.chemosphere.2008.05.054
115. Kojima, H., Gu, H., Nomura, S., Caldwell, C. C., Kobata, T., Carmeliet, P., et al. (2002). Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha-deficient chimeric mice. Proc. Natl. Acad. Sci. U.S.A. 99, 2170-2174. doi:10.1073/pnas.052706699
116. Kokkola, R., Andersson, A., Mullins, G., Ostberg, T., Treutiger, C. J., Arnold, B., et al. (2005). RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61, 1-9. doi:10.1111/j.0300-9475.2005.01534.x
117. Kokkola, R., Li, J., Sundberg, E., Aveberger, A. C., Palmblad, K., Yang, H., et al. (2003). Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48, 2052-2058. doi:10.1002/art.11161
118. Konttinen, Y. T., Mackiewicz, Z., Povilenaite, D., Sukura, A., Hukkanen, M., and Virtanen, I. (2004). Disease-associated increased HIF-1, alphavbeta3 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels in inflammatory myopathies. Rheumatol. Int. 24, 333-339. doi:10.1007/s00296-003-0379-z
119. Krysko, D. V., Agostinis, P., Krysko, O., Garg, A. D., Bachert, C., Lambrecht, B. N., et al. (2011). Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 32, 157-164. doi:10.1016/j.it.2011.01.005
120. Kuhlicke, J., Frick, J. S., Morote-Garcia, J. C., Rosenberger, P., and Eltzschig, H. K. (2007). Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2:e1364. doi:10.1371/journal.pone.0001364
121. Kwak, D., Choi, S., Jeong, H., Jang, J.-H., Lee, Y., Jeon, H., et al. (2012). Osmotic stress regulates mammalian target of rapamycin (mTOR) complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor protein phosphorylation. J. Biol. Chem. 287, 18398-18407. doi:10.1074/jbc.M111.326538
122. Lamkanfi, M., and Dixit, V. M. (2012). Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28, 137-161. doi:10.1146/annurev-cellbio-101011-155745
123. Land, W. G., and Messmer, K. (2012). The danger theory in view of the injury hypothesis: 20 years later. Front. Immunol. 3:349. doi:10.3389/fimmu.2012.00349
124. Lang, P., Merkler, D., Funkner, P., Shaabani, N., Meryk, A., Krings, C., et al. (2010). Oxidized ATP inhibits T-cell-mediated autoimmunity. Eur. J. Immunol. 40, 2401-2408. doi:10.1002/eji.200939838
125. Lardner, A. (2001). The effects of extracellular pH on immune function. J. Leukoc. Biol. 69, 522-530.
126. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., and Marshak-Rothstein, A. (2002). Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607. doi:10.1038/416603a
127. Lee-Kirsch, M. A., Chowdhury, D., Harvey, S., Gong, M., Senenko, L., Engel, K., et al. (2007a). A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J. Mol. Med. (Berl.) 85, 531-537. doi:10.1007/s00109-007-0199-9
128. Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y. A., et al. (2007b). Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065-1067. doi:10.1038/ng2091
129. Li, A., Qin, L., Zhu, D., Zhu, R., Sun, J., and Wang, S. (2010). Signalling pathways involved in the activation of dendritic cells by layered double hydroxide nanoparticles. Biomaterials 31, 748-756. doi:10.1016/j.biomaterials.2009.09.095
130. Lin, M., Yiu, W., Wu, H., Chan, L. Y., Leung, J., Au, W., et al. (2012). Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J. Am. Soc. Nephrol. 23, 86-102. doi:10.1681/ASN.2010111210
131. Liu, B., Dai, J., Zheng, H., Stoilova, D., Sun, S., and Li, Z. (2003). Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc. Natl. Acad. Sci. U.S.A. 100, 15824-15829. doi:10.1073/pnas.2635458100
132. Liu, Y. J. (2005). IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306. doi:10.1146/annurev.immunol.23.021704.115633
133. Lotze, M. T., and Tracey, K. J. (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342. doi:10.1038/nri1594
134. Maeno, E., Ishizaki, Y., Kanaseki, T., Hazama, A., and Okada, Y. (2000). Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. U.S.A. 97, 9487-9492. doi:10.1073/pnas.140216197
135. Maeno, E., Shimizu, T., and Okada, Y. (2006). Normotonic cell shrinkage induces apoptosis under extracellular low Cl conditions in human lymphoid and epithelial cells. Acta Physiol (Oxf.) 187, 217-222. doi:10.1111/j.1748-1716.2006.01554.x
136. Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., Chen, I. H., et al. (2008). Divergent effects of hypoxia on dendritic cell functions. Blood 112, 3723-3734. doi:10.1182/blood-2008-02-142091
137. Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., and Bachmann, M. F. (2008). Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404-1413. doi:10.1002/eji.200737984
138. Mariathasan, S., Newton, K., Monack, D., Vucic, D., French, D., Lee, W., et al. (2004). Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218. doi:10.1038/nature02664
139. Marriott, I., Inscho, E. W., and Bost, K. L. (1999). Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells. Cell. Immunol. 195, 147-156. doi:10.1006/cimm.1999.1531
140. Marshak-Rothstein, A., and Rifkin, I. R. (2007). Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25, 419-441. doi:10.1146/annurev.immunol.22.012703.104514
141. Martinez, D., Vermeulen, M., Trevani, A. A., Ceballos, A., Sabatté, J., Gamberale, R., et al. (2006). Extracellular acidosis induces neutrophil activation by a mechanism dependent on activation of phosphatidylinositol 3-kinase/Akt and ERK pathways. J. Immunol. 176, 1163-1171.
142. Martinez-Zaguilan, R., Seftor, E. A., Seftor, R. E., Chu, Y. W., Gillies, R. J., and Hendrix, M. J. (1996). Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 14, 176-186. doi:10.1007/BF00121214
143. Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006). Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241. doi:10.1038/nature04516
144. Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045. doi:10.1146/annurev.immunol.12.1.991
145. Matzinger, P. (1998). An innate sense of danger. Semin. Immunol. 10, 399-415. doi:10.1006/smim.1998.0143
146. Matzinger, P. (2002). The danger model: a renewed sense of self. Science 296, 301-305. doi:10.1126/science.1071059
147. Medzhitov, R., and Janeway, C. A. Jr. (1997a). Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295-298. doi:10.1016/S0092-8674(00)80412-2
148. Medzhitov, R., and Janeway, C. A. Jr. (1997b). Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9, 4-9. doi:10.1016/S0952-7915(97)80152-5
149. Medzhitov, R., Preston-Hurlburt, P., and Janeway, C. A. Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397. doi:10.1038/41131
150. Melli, K., Friedman, R. S., Martin, A. E., Finger, E. B., Miao, G., Szot, G. L., et al. (2009). Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J. Immunol. 182, 2590-2600. doi:10.4049/jimmunol.0803543
151. Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N. A., Bogdan, C., et al. (2002). Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15-21. doi:10.1084/jem.20011341
152. Metselaar, J. M., Wauben, M. H., Wagenaar-Hilbers, J. P., Boerman, O. C., and Storm, G. (2003). Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 48, 2059-2066. doi:10.1002/art.11140
153. Millar, D. G., Garza, K. M., Odermatt, B., Elford, A. R., Ono, N., Li, Z., et al. (2003). Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat. Med. 9, 1469-1476. doi:10.1038/nm962
154. Miller, J. C., Brown, B. D., Shay, T., Gautier, E. L., Jojic, V., Cohain, A., et al. (2012). Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13, 888-899. doi:10.1038/ni.2370
155. Mills, K. H. (2011). TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11, 807-822. doi:10.1038/nri3095
156. Mitchell, L. A., Lauer, F. T., Burchiel, S. W., and Mcdonald, J. D. (2009). Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat. Nanotechnol. 4, 451-456. doi:10.1038/nnano.2009.151
157. Moghimi, S. M. (2002). Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. Biochim. Biophys. Acta 1590, 131-139. doi:10.1016/S0167-4889(02)00204-5
158. Mohamed, B. M., Verma, N. K., Davies, A. M., Mcgowan, A., Crosbie-Staunton, K., Prina-Mello, A., et al. (2012). Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo. Nanomed. 7, 1181-1195. doi:10.2217/nnm.11.177
159. Morita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., et al. (2004). Gene-targeted mice lacking the Trex1 (DNase III) 3' →5'DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 24, 6719-6727. doi:10.1128/MCB.24.15.6719-6727.2004
160. Muller, T., Robaye, B., Vieira, R. P., Ferrari, D., Grimm, M., Jakob, T., et al. (2010). The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 65, 1545-1553. doi:10.1111/j.1398-9995.2010.02426.x
161. Muslimani, A., Chisti, M. M., Wills, S., Nadeau, L., Zakalik, D., Daw, H., et al. (2011). How we treat tumor lysis syndrome. Oncology (Williston Park, N.Y.) 25, 369-375.
162. Mutini, C., Falzoni, S., Ferrari, D., Chiozzi, P., Morelli, A., Baricordi, O. R., et al. (1999). Mouse dendritic cells express the P2×7 purinergic receptor: characterization and possible participation in antigen presentation. J. Immunol. 163, 1958-1965.
163. Nedergaard, M., Kraig, R. P., Tanabe, J., and Pulsinelli, W. A. (1991). Dynamics of interstitial and intracellular pH in evolving brain infarct. Am. J. Physiol. 260, R581-R588.
164. Niewold, T. (2011). Interferon alpha as a primary pathogenic factor in human lupus. J. Interferon Cytokine Res. 31, 887-892. doi:10.1089/jir.2011.0071
165. Nin, J., Ferreira, I., Schalkwijk, C., Jorsal, A., Prins, M., Parving, H. H., et al. (2012a). Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study. Diabetologia 55, 2489-2493. doi:10.1007/s00125-012-2622-1
166. Nin, J., Ferreira, I., Schalkwijk, C., Prins, M., Chaturvedi, N., Fuller, J., et al. (2012b). Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. Eur. J. Endocrinol. 166, 325-332. doi:10.1530/EJE-11-0662
167. Nizet, V., and Johnson, R. S. (2009). Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609-617. doi:10.1038/nri2607
168. Oates, J. C., and Gilkeson, G. S. (2006). The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin. Immunol. 121, 243-250. doi:10.1016/j.clim.2006.06.001
169. Odegaard, J., and Chawla, A. (2013). The immune system as a sensor of the metabolic state. Immunity 38, 644-654. doi:10.1016/j.immuni.2013.04.001
170. Ohnmacht, C., Pullner, A., King, S. B., Drexler, I., Meier, S., Brocker, T., et al. (2009). Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206, 549-559. doi:10.1084/jem.20082394
171. Park, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., et al. (2004). Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279, 7370-7377. doi:10.1074/jbc.M306793200
172. Pearce, E., and Pearce, E. (2013). Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633-643. doi:10.1016/j.immuni.2013.04.005
173. Perl, A., Gergely, P. Jr, Nagy, G., Koncz, A., and Banki, K. (2004). Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 25, 360-367. doi:10.1016/j.it.2004.05.001
174. Perl, A., Hanczko, R., and Doherty, E. (2012). Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol. Biol. 900, 61-89. doi:10.1007/978-1-60761-720-4_4
175. Peyssonnaux, C., Datta, V., Cramer, T., Doedens, A., Theodorakis, E. A., Gallo, R. L., et al. (2005). HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115, 1806-1815. doi:10.1172/JCI23865
176. Pichlmair, A., and Reis e Sousa, C. (2007). Innate recognition of viruses. Immunity 27, 370-383. doi:10.1016/j.immuni.2007.08.012
177. Pisitkun, P., Deane, J. A., Difilippantonio, M. J., Tarasenko, T., Satterthwaite, A. B., and Bolland, S. (2006). Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669-1672. doi:10.1126/science.1124978
178. Pociot, F., Ronningen, K. S., and Nerup, J. (1993). Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70-2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand. J. Immunol. 38, 491-495. doi:10.1111/j.1365-3083.1993.tb02593.x
179. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088. doi:10.1126/science.282.5396.2085
180. Ramachandran, S., and Bell, R. B. (1995). Heat shock protein 70 gene polymorphisms and multiple sclerosis. Tissue Antigens 46, 140-141. doi:10.1111/j.1399-0039.1995.tb02492.x
181. Ratanachaiyavong, S., Demaine, A. G., Campbell, R. D., and Mcgregor, A. M. (1991). Heat shock protein 70 (HSP70) and complement C4 genotypes in patients with hyperthyroid Graves' disease. Clin. Exp. Immunol. 84, 48-52.
182. Rath, E., and Haller, D. (2012). Mitochondria at the interface between danger signaling and metabolism: role of unfolded protein responses in chronic inflammation. Inflamm. Bowel Dis. 18, 1364-1377. doi:10.1002/ibd.21944
183. Reis e Sousa, C. (2006). Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483. doi:10.1038/nri1845
184. Rescigno, M. (2010). Intestinal dendritic cells. Adv. Immunol. 107, 109-138. doi:10.1016/B978-0-12-381300-8.00004-6
185. Ridge, J. P., Di Rosa, F., and Matzinger, P. (1998). A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474-478. doi:10.1038/30989
186. Riteau, N., Baron, L., Villeret, B., Guillou, N., Savigny, F., Ryffel, B., et al. (2012). ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 3, e403. doi:10.1038/cddis.2012.144
187. Robinson, A. P., Caldis, M. W., Harp, C. T., Goings, G. E., and Miller, S. D. (2013). High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. J. Autoimmun. 43, 32-43. doi:10.1016/j.jaut.2013.02.005
188. Robson, S., Sévigny, J., and Zimmermann, H. (2006). The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal. 2, 409-430. doi:10.1007/s11302-006-9003-5
189. Rock, K. L., Kataoka, H., and Lai, J. J. (2013). Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 9, 13-23. doi:10.1038/nrrheum.2012.143
190. Rock, K. L., and Kono, H. (2008). The inflammatory response to cell death. Annu. Rev. Pathol. 3, 99-126. doi:10.1146/annurev.pathmechdis.3.121806.151456
191. Rock, K. L., Latz, E., Ontiveros, F., and Kono, H. (2010). The sterile inflammatory response. Annu. Rev. Immunol. 28, 321-342. doi:10.1146/annurev-immunol-030409-101311
192. Rofstad, E. K., Mathiesen, B., Kindem, K., and Galappathi, K. (2006). Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 66, 6699-6707. doi:10.1158/0008-5472.CAN-06-0983
193. Rosmalen, J. G., Homo-Delarche, F., Durant, S., Kap, M., Leenen, P. J., and Drexhage, H. A. (2000). Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NODscid mice. Lab. Invest. 80, 769-777. doi:10.1038/labinvest.3780080
194. Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400. doi:10.1084/jem.182.2.389
195. Salvador-Morales, C., Flahaut, E., Sim, E., Sloan, J., Green, M. L. H., and Sim, R. B. (2006). Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 43, 193-201. doi:10.1016/j.molimm.2005.02.006
196. Santiago-Raber, M. L., Baudino, L., and Izui, S. (2009). Emerging roles of TLR7 and TLR9 in murine SLE. J. Autoimmun. 33, 231-238. doi:10.1016/j.jaut.2009.10.001
197. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. (2000). Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells [see comments]. J. Exp. Med. 191, 423-434. doi:10.1084/jem.191.3.423
198. Scaffidi, P., Misteli, T., and Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195. doi:10.1038/nature00858
199. Schiraldi, M., and Monestier, M. (2009). How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends Immunol. 30, 502-509. doi:10.1016/j.it.2009.07.005
200. Schiraldi, M., Raucci, A., Munoz, L. M., Livoti, E., Celona, B., Venereau, E., et al. (2012). HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 209, 551-563. doi:10.1084/jem.20111739
201. Schorn, C., Strysio, M., Janko, C., Munoz, L. E., Schett, G., and Herrmann, M. (2010). The uptake by blood-borne phagocytes of monosodium urate is dependent on heat-labile serum factor(s) and divalent cations. Autoimmunity 43, 236-238. doi:10.3109/08916930903510948
202. Semenza, G. L. (2009). Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24, 97-106. doi:10.1152/physiol.00045.2008
203. Seong, S.-Y., and Matzinger, P. (2004). Opinion: hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478. doi:10.1038/nri1372
204. Sethi, V., Rubinstein, I., Kuzmis, A., Kastrissios, H., Artwohl, J., and Onyuksel, H. (2013). Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis. Mol. Pharm. 10, 728-738. doi:10.1021/mp300539f
205. Seuwen, K., Ludwig, M.-G., and Wolf, R. M. (2006). Receptors for protons or lipid messengers or both? J. Recept. Signal Transduct. Res. 26, 599-610. doi:10.1080/10799890600932220
206. Shapiro, L., and Dinarello, C. (1995). Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. U.S.A. 92, 12230-12234. doi:10.1073/pnas.92.26.12230
207. Sharp, A. J., Polak, P. E., Simonini, V., Lin, S. X., Richardson, J. C., Bongarzone, E. R., et al. (2008). P2×7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J. Neuroinflammation 5:33. doi:10.1186/1742-2094-5-33
208. Shaw, P. J., Lukens, J. R., Burns, S., Chi, H., Mcgargill, M. A., and Kanneganti, T. D. (2010). Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J. Immunol. 184, 4610-4614. doi:10.4049/jimmunol.1000217
209. Shi, Y., Evans, J. E., and Rock, K. L. (2003). Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521. doi:10.1038/nature01991
210. Shi, Y., Zheng, W., and Rock, K. L. (2000). Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. U.S.A. 97, 14590-14595. doi:10.1073/pnas.260497597
211. Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., et al. (2008). Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J. Immunol. 180, 7175-7183.
212. Shirali, A. C., and Goldstein, D. R. (2008). Activation of the innate immune system by the endogenous ligand hyaluronan. Curr. Opin. Organ Transplant 13, 20-25. doi:10.1097/MOT.0b013e3282f3df04
213. Sica, A., Melillo, G., and Varesio, L. (2011). Hypoxia: a double-edged sword of immunity. J. Mol. Med. 89, 657-665. doi:10.1007/s00109-011-0724-8
214. Simmen, H. P., and Blaser, J. (1993). Analysis of pH and pO2 in abscesses, peritoneal fluid, and drainage fluid in the presence or absence of bacterial infection during and after abdominal surgery. Am. J. Surg. 166, 24-27. doi:10.1016/S0002-9610(05)80576-8
215. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., and Coyle, A. J. (2010). HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28, 367-388. doi:10.1146/annurev.immunol.021908.132603
216. Spirig, R., Djafarzadeh, S., Regueira, T., Shaw, S. G., Von Garnier, C., Takala, J., et al. (2010). Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions. PLoS ONE 5:e10983. doi:10.1371/journal.pone.0010983
217. Sriram, U., Varghese, L., Bennett, H. L., Jog, N. R., Shivers, D. K., Ning, Y., et al. (2012). Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset. J. Immunol. 189, 80-91. doi:10.4049/jimmunol.1101686
218. Srivastava, P. (2002). Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2, 185-194. doi:10.1038/nri749
219. Steinman, R. M., Hawiger, D., and Nussenzweig, M. C. (2003). Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711. doi:10.1146/annurev.immunol.21.120601.141040
220. Stern, S. T., and McNeil, S. E. (2008). Nanotechnology safety concerns revisited. Toxicol. Sci. 101, 4-21. doi:10.1093/toxsci/kfm169
221. Stetson, D. B., Ko, J. S., Heidmann, T., and Medzhitov, R. (2008). Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598. doi:10.1016/j.cell.2008.06.032
222. Stocki, P., and Dickinson, A. M. (2012). The immunosuppressive activity of heat shock protein 70. Autoimmune Dis 2012, 617213. doi:10.1155/2012/617213
223. Stoecklein, V. M., Osuka, A., and Lederer, J. A. (2012). Trauma equals danger - damage control by the immune system. J. Leukoc. Biol. 92, 539-551. doi:10.1189/jlb.0212072
224. Stoye, J. P. (2012). Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat. Rev. Microbiol. 10, 395-406. doi:10.1038/nrmicro2783
225. Stranger, B. E., and De Jager, P. L. (2012). Coordinating GWAS results with gene expression in a systems immunologic paradigm in autoimmunity. Curr. Opin. Immunol. 24, 544-551. doi:10.1016/j.coi.2012.09.002
226. Tang, D., Billiar, T., and Lotze, M. (2012). A Janus tale of two active high mobility group box 1 (HMGB1) redox states. Mol. Med. 18, 1360-1362. doi:10.2119/molmed.2012.00314
227. Taniguchi, T., and Takaoka, A. (2002). The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14, 111-116. doi:10.1016/S0952-7915(01)00305-3
228. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., et al. (2002). Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195, 99-111. doi:10.1084/jem.20001858
229. Theofilopoulos, A. N., Baccala, R., Beutler, B., and Kono, D. H. (2005). Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23, 307-336. doi:10.1146/annurev.immunol.23.021704.115843
230. Thompson, M. R., Kaminski, J. J., Kurt-Jones, E. A., and Fitzgerald, K. A. (2011). Pattern recognition receptors and the innate immune response to viral infection. Viruses 3, 920-940. doi:10.3390/v3060920
231. Tomura, H., Mogi, C., Sato, K., and Okajima, F. (2005). Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors. Cell. Signal. 17, 1466-1476. doi:10.1016/j.cellsig.2005.06.002
232. Tong, J., Wu, W.-N., Kong, X., Wu, P.-F., Tian, L., Du, W., et al. (2011). Acid-sensing ion channels contribute to the effect of acidosis on the function of dendritic cells. J. Immunol. 186, 3686-3692. doi:10.4049/jimmunol.1001346
233. Toscano, M. G., Delgado, M., Kong, W., Martin, F., Skarica, M., and Ganea, D. (2010). Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs. Mol. Ther. 18, 1035-1045. doi:10.1038/mt.2009.293
234. Treuhaft, P. S., and McCarty, D. J. (1971). Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheumat. 14, 475-484.
235. Trevani, A. S., Andonegui, G., Giordano, M., López, D. H., Gamberale, R., Minucci, F., et al. (1999). Extracellular acidification induces human neutrophil activation. J. Immunol. 162, 4849-4857.
236. Ulbrich, W., and Lamprecht, A. (2010). Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases. J. R. Soc. Interface 7(Suppl. 1), S55-66. doi:10.1098/rsif.2009.0285.focus
237. Upton, J. W., Kaiser, W. J., and Mocarski, E. S. (2010). Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7, 302-313. doi:10.1016/j.chom.2010.03.006
238. Urbonaviciute, V., Furnrohr, B. G., Meister, S., Munoz, L., Heyder, P., De Marchis, F., et al. (2008). Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205, 3007-3018. doi:10.1084/jem.20081165
239. Urbonaviciute, V., and Voll, R. E. (2011). High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. J. Intern. Med. 270, 309-318. doi:10.1111/j.1365-2796.2011.02432.x
240. Vabulas, R. M., Wagner, H., and Schild, H. (2002). Heat shock proteins as ligands of toll-like receptors. Curr. Top. Microbiol. Immunol. 270, 169-184. doi:10.1007/978-3-642-59430-4_11
241. Valko, M., Leibfritz, D., Moncol, J., Cronin, M., Mazur, M., and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84. doi:10.1016/j.biocel.2006.07.001
242. Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., and Kroemer, G. (2010). Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700-714. doi:10.1038/nrm2970
243. Vermeulen, M. N., Giordano, M., Trevani, A. S., Sedlik, C., Gamberale, R., Fernández-Calotti, P., et al. (2004). Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells. J. Immunol. 172, 3196-3204.
244. Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., et al. (2005). Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med. 201, 105-115. doi:10.1084/jem.20040624
245. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., et al. (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251. doi:10.1126/science.285.5425.248
246. Wang, Q., Liu, C., Zhu, F., Liu, F., Zhang, P., Guo, C., et al. (2010). Reoxygenation of hypoxia-differentiated dendritic cells induces Th1 and Th17 cell differentiation. Mol. Immunol. 47, 922-931. doi:10.1016/j.molimm.2009.09.038
247. Witte, M. E., Geurts, J. J. G., De Vries, H. E., Van Der Valk, P., and Van Horssen, J. (2010). Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10, 411-418. doi:10.1016/j.mito.2010.05.014
248. Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., et al. (2013). Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513-517. doi:10.1038/nature11984
249. Wu, T., Xie, C., Han, J., Ye, Y., Weiel, J., Li, Q., et al. (2012). Metabolic disturbances associated with systemic lupus erythematosus. PLoS ONE 7:e37210. doi:10.1371/journal.pone.0037210
250. Yang, D., De La Rosa, G., Tewary, P., and Oppenheim, J. J. (2009). Alarmins link neutrophils and dendritic cells. Trends Immunol. 30, 531-537. doi:10.1016/j.it.2009.07.004
251. Yang, H., Antoine, D. J., Andersson, U., and Tracey, K. J. (2013). The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J. Leukoc. Biol. 93, 865-873. doi:10.1189/jlb.1212662
252. Yang, H., Wang, H., Czura, C. J., and Tracey, K. J. (2005). The cytokine activity of HMGB1. J. Leukoc. Biol. 78, 1-8. doi:10.1189/jlb.1104648
253. Yang, Y. G., Lindahl, T., and Barnes, D. E. (2007). Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131, 873-886. doi:10.1016/j.cell.2007.10.017
254. Yao, D., and Brownlee, M. (2010). Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 59, 249-255. doi:10.2337/db09-0801
255. Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L., and Quintana, F. J. (2012). Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 109, 11270-11275. doi:10.1073/pnas.1120611109
256. Zeiser, R., Penack, O., Holler, E., and Idzko, M. (2011). Danger signals activating innate immunity in graft-versus-host disease. J. Mol. Med. 89, 833-845. doi:10.1007/s00109-011-0767-x
257. Zetterstrom, C. K., Jiang, W., Wahamaa, H., Ostberg, T., Aveberger, A. C., Schierbeck, H., et al. (2008). Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate. J. Leukoc. Biol. 83, 31-38. doi:10.1189/jlb.0507323
258. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107. doi:10.1038/nature08780
259. Zhang, S., Zhong, J., Yang, P., Gong, F., and Wang, C. Y. (2009). HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int. J. Clin. Exp. Pathol. 3, 24-38.
260. Zitvogel, L., and Kroemer, G. (2010). The multifaceted granulysin. Blood 116, 3379-3380. doi:10.1182/blood-2010-08-299214
261. Zolnik, B. S., González-Fernández, Å, Sadrieh, N., and Dobrovolskaia, M. A. (2010). Minireview: nanoparticles and the immune system. Endocrinology 151, 458-465. doi:10.1210/en.2009-1082